Vascular Closure Devices Market Size Worth USD 1.9 Billion by 2030 at 7.30% CAGR - Report by Market Research Future (MRFR)
October 06, 2022 11:30 ET
|
Market Research Future
New York, USA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Vascular Closure Devices Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vascular Closure Device...
Teleflex Announces First Patient Enrollment in MANTA Ultra Study
June 22, 2022 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study...
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
May 18, 2022 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the...
Access Vascular Inc. and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
October 27, 2021 08:00 ET
|
Access Vascular
BEDFORD, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has formed a...
New Access Vascular Clinical Studies Find Catheters Composed of Advanced Biomaterials Significantly Reduce Complication Rates
September 20, 2021 08:00 ET
|
Access Vascular
BEDFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
June 23, 2021 09:00 ET
|
RapidPulse, Inc
MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15...
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
April 08, 2021 18:58 ET
|
BioAegis Therapeutics
Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression. Gelsolin is non-immunosuppressive unlike current treatments to quell...
Velano’s PIVO™ Named 2018 MedTech Breakthrough Awards’ Best Overall Medical Device Solution
June 06, 2018 13:06 ET
|
Velano Vascular
SAN FRANCISCO, June 06, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular’s PIVO™ needle-free device for blood draws was named Best Overall Medical Device Solution by the...
Velano Vascular Named 2018’s Gold Edison Award™ Winner
April 17, 2018 08:00 ET
|
Velano Vascular
SAN FRANCISCO, April 17, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular today announced that its PIVO™ needle-free device for blood draws was named the 2018 Gold...
Velano Vascular to Address Healthcare Innovation at Upcoming Spring Conferences
April 10, 2018 08:00 ET
|
Velano Vascular
SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular today announced that company leadership will present at a number of premier healthcare...